About

At Bicoll, we are committed to delivering breakthrough solutions in longevity and improving the lives of patients with neurodegenerative disorders such as epilepsy. Our innovative and efficient multi-disciplinary technology approach to the discovery of novel potent molecules for the pharmaceutical, nutraceutical, and agricultural industry is second to none. With a proven track record of success, Bicoll's plant-based small molecule libraries have been documented in peer-reviewed publications and patents, demonstrating their efficacy in a wide range of applications. Looking to stay ahead of the curve in the highly competitive field of pharmaceuticals? Look no further than Bicoll, the expert in the field of plant small molecules backed up by strong medicinal chemistry. About Bicoll GmbH At Bicoll we're committed to pushing the boundaries of innovation and harnessing the power of existing compounds to address pressing healthcare challenges. Our latest endeavors in one of the projects have shown promising achievement for the landscape of anti-inflammatory treatments, CNS and taste-modulation. 1. We're delving deep into the vast pool of existing compounds, uncovering hidden potentials and repurposing them for anti-inflammatory purposes. 2. Our dedicated team of researchers is employing cutting-edge techniques and methodologies to identify compounds with promising anti-inflammatory properties and novel pathways and mechanisms of action. 3. Collaboration is at the heart of our project. By partnering with esteemed institutions and industry experts, we're fostering synergies and pooling our collective expertise to drive meaningful progress. Our ultimate goal extends beyond scientific advancement. A pioneer in the realm of drug discovery: it has consistently demonstrated unparalleled proficiency in the extraction and isolation of bioactive compounds from natural sources. I. Agriculture: Explore new horizons in agriculture through a strategic partnership with Bicoll. Pioneering novel structures and small molecules that can elevate your compound discovery program II. Adapalene re-purposing: Partnership/out-licensing for a re-purposing small molecule with clear mode of action and IP (patent published) III. Nutraceuticsls - Taste and flavor: Innovate and formulate new alternatives to the ingredients that are the target of sugar taxes. Creating novel sweeteners, flavor enhancers, or other compounds IV. Neuroscience: New chemical entity in the preclinical development: antiepileptic drugs for companion animals. 4NEURON - new spin-off - lead small molecule to change the lives of 50 Mio. Epilepsy patients. V. Compound library and medicinal chemistry: Uncover "dark matter" of medicinal plants. Fresh ideas for your screening About Bicoll GmbH At Bicoll we're committed to pushing the boundaries of innovation and harnessing the power of existing compounds to address pressing healthcare challenges. Our latest endeavors in one of the projects have shown promising achievement for the landscape of anti-inflammatory treatments, CNS and taste-modulation. 1. We're delving deep into the vast pool of existing compounds, uncovering hidden potentials and repurposing them for anti-inflammatory purposes. 2. Our dedicated team of researchers is employing cutting-edge techniques and methodologies to identify compounds with promising anti-inflammatory properties and novel pathways and mechanisms of action. 3. Collaboration is at the heart of our project. By partnering with esteemed institutions and industry experts, we're fostering synergies and pooling our collective expertise to drive meaningful progress. Our ultimate goal extends beyond scientific advancement. A pioneer in the realm of drug discovery: it has consistently demonstrated unparalleled proficiency in the extraction and isolation of bioactive compounds from natural sources. I. Agriculture: Explore new horizons in agriculture through a strategic partnership with Bicoll. Pioneering novel structures and small molecules that can elevate your compound discovery program II. Adapalene re-purposing: Partnership/out-licensing for a re-purposing small molecule with clear mode of action and IP (patent published) III. Nutraceuticsls - Taste and flavor: Innovate and formulate new alternatives to the ingredients that are the target of sugar taxes. Creating novel sweeteners, flavor enhancers, or other compounds IV. Neuroscience: New chemical entity in the preclinical development: antiepileptic drugs for companion animals. 4NEURON - new spin-off - lead small molecule to change the lives of 50 Mio. Epilepsy patients. V. Compound library and medicinal chemistry: Uncover "dark matter" of medicinal plants. Fresh ideas for your screening Bicoll is a trusted leader in biopharmaceutical drug discovery, specializing in high-tech natural product and medicinal chemistry to identify novel, small-molecule compounds that power the future of pharmaceuticals and beyond. Leveraging advanced techniques in natural compound identification and chemical synthesis, Bicoll accelerates the discovery of new drug candidates, providing companies with unique, high-potential compounds for preclinical research. Bicoll's expertise extends to transformative solutions across pharmaceuticals, cosmetics, nutraceuticals, and agriculture, enabling partners to achieve breakthrough results with safe, effective, and innovative products. From Breakthrough Ideas to Life-Changing Solutions: See You at #BIO2025 in San Francisco! Not long ago, a family struggling with epilepsy shared their story with us—a story of endless challenges, countless medications, and the hope for a better future. Stories like theirs drive our mission at Bicoll every day: to turn complex scientific challenges into life-changing breakthroughs. The Problem: Discovering innovative treatments for conditions like epilepsy isn’t just about science—it’s about the people waiting for answers. At Bicoll, we believe in breaking barriers in drug discovery to deliver those answers faster, safer, and more effectively. The Solution: After years of relentless research, our team developed a game-changing small molecule. Tested in acute viable brain slices from multi-drug-resistant epilepsy patients, it has shown exceptional anti-seizure efficacy and an extraordinary reduction in side effects. This isn’t just progress; it’s a leap toward redefining epilepsy care and restoring hope. The Bigger Picture: Bicoll’s innovative approach to natural product and medicinal chemistry extends beyond epilepsy. From pharmaceuticals to cosmetics, nutraceuticals, and agriculture, we’re unlocking the potential of nature to create high-impact, safe, and transformative solutions.